Comparative study between synthetic and phospholipids of natural origin: effect of phospholipid selection on the behavior of a topical liposomal dosage form incorporating terbinafine.
Selection of excipients used is a critical step in the design of a pharmaceutical dosage form as it affects its behavior upon application, as during storage. The purpose of the present study is to evaluate and compare the behavior of six liposomal formulations intended for topical application composed of two widely used phospholipids 1,2-diacyl-sn-glycero-3-phosphocholine and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine with and without incorporation of cholesterol. Liposomal hydrogels made of hydroxyethylcellulose 3% and incorporating the anti-fungal agent terbinafine hydrochloride (E)-N-(6,6-dimethyl-2-hepten-4-inyl)-N-methyl-1-naphthalene-methanamine (-hydrochloride) were prepared, their viscosity was measured and in vitro drug release was studied. Moreover, physical stability and drug retention during storage at two different temperatures (2-8 °C and RT) were examined over time. The results showed differences in the behavior between the two phospholipids while incorporation of cholesterol at the studied concentrations was found to be of minor importance. Drug release was found to be favorable from 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) liposomal hydrogels and drug retention was found to be higher at lower storage temperature for all batches. Original physicochemical properties of all batches were found to be retained at least for a week.
Faculty of Pharmacy, Department of Galenic Pharmacy, Comenius University in Bratislava , Odbojárov, Bratislava , Slovakia and.
Charalampos
C
Koutsoulas
Ehsan
E
Suleiman
Andreas
A
Wagner
Marian
M
Žabka
D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage / Q000737:chemistry*; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry*; D004339:Drug Compounding; D004355:Drug Stability; D004356:Drug Storage; D020100:Hydrogels; D008081:Liposomes; D009281:Naphthalenes / Q000008:administration & dosage / Q000737:chemistry*; D010743:Phospholipids / Q000138:chemical synthesis / Q000737:chemistry*; D012995:Solubility; D000077291:Terbinafine; D014783:Viscosity
D000935:Antifungal Agents; D004337:Drug Carriers; D020100:Hydrogels; D008081:Liposomes; D009281:Naphthalenes; D010743:Phospholipids; D000077291:Terbinafine
Drug retention; in vitro drug release; liposomes; terbinafine hydrochloride; topical administration